Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Syndecan-1 Blocking Peptide (AC1314)
Cat.#: ACPP-1314
Specifications
Despition Syndecan-1 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1356 GIRK2 Blocking Peptide (AC1356) 250 µg inquiry ACPP-1383 Human KLF7 Protein (AC1383) 5 µg inquiry ACPP-1270 Luteinizing Hormone Blocking Peptide (AC1270) 250 µg inquiry ACPP-1802 Human STAC Protein (AC1802) 5 µg inquiry ACPP-1048 Recombinant Human Butyrylcholinesterase Protein (6×His Tag) (AC1048) 50 µg inquiry ACPP-1453 Human ACOT7 Protein (AC1453) 5 µg inquiry ACPP-1545 Human YWHAG Protein (AC1545) 5 µg inquiry ACPP-1524 Human TARDBP (1-414) Protein (AC1524) 5 µg inquiry ACPP-1151 Recombinant HuD Protein (AC1151) 10 µg inquiry ACPP-1034 Recombinant Human NG2 Protein (6×His Tag) (AC1034) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket